APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bovine Blood Plasma Derivatives

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.

Selected research

Industry Growth & Trends

Global Bovine Blood Plasma Derivatives Industry Growth and Trends Forecast to 2032

21 December 2025127 pages

Choose your research edition.

Industry ResearchBovine Blood Plasma Derivatives Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Bovine Blood Plasma Derivatives Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Bovine Blood Plasma Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bovine Blood Plasma Derivatives Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Bovine Blood Plasma Derivatives Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.

Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.

Read the full market overview

In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.

Report Scope

This report provides a structured, data-driven view of the global Bovine Blood Plasma Derivatives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bovine Blood Plasma Derivatives market size, estimates, and forecasts are presented in terms of sales volume (K Liters) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bovine Blood Plasma Derivatives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bovine Blood Plasma Derivatives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bovine Blood Plasma Derivatives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bovine Blood Plasma Derivatives Market by Company

Thermo Fisher

GE Healthcare

Merck (Sigma-Aldrich)

Moregate BioTech

Gemini

Atlanta Biologicals

Tissue Culture Biologicals

Bovogen

Biowest

Internegocios

RMBIO

Biological Industries

VWR

Corning

Serana

Lanzhou Minhai

Zhejiang Tianhang Biotechnology

ExCell Bio

Jin Yuan Kang

American Protein Company

Sonac

Bovine Blood Plasma Derivatives Segment by Type

Bovine Serum

FBS

Bovine Serum Albumin

Fibrinogen

Protein Ingredient

Other

Bovine Blood Plasma Derivatives Segment by Application

Scientific Research

Industrial Production

Feed

Others

Bovine Blood Plasma Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Plasma Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Blood Plasma Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Plasma Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bovine Blood Plasma Derivatives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bovine Blood Plasma Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bovine Serum Table 2. Major Company of FBS Table 3. Major Company of Bovine Serum Albumin Table 4. Major Company of Fibrinogen Table 5. Major Company of Protein Ingredient Table 6. Major Company of Other Table 7. Global Bovine Blood Plasma Derivatives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (K Liters) Table 9. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type (2021-2026) Table 10. Global Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (US$ Million) Table 11. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Type (2021-2026) Table 12. Global Bovine Blood Plasma Derivatives Price by Type (2021-2026) & (USD/L) Table 13. Global Bovine Blood Plasma Derivatives Sales by Type (2027-2032) & (K Liters) Table 14. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type (2027-2032) Table 15. Global Bovine Blood Plasma Derivatives Sales by Type (2027-2032) & (US$ Million) Table 16. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Type (2027-2032) Table 17. Global Bovine Blood Plasma Derivatives Price by Type (2027-2032) & (USD/L) Table 18. North America Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (K Liters) Table 19. North America Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (K Liters) Table 21. Europe Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (K Liters) Table 23. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (K Liters) Table 25. Latin America Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (K Liters) Table 27. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Type (2021-2026) & (US$ Million) Table 28. Bovine Blood Plasma Derivatives Industry Trends Table 29. Bovine Blood Plasma Derivatives Industry Drivers Table 30. Bovine Blood Plasma Derivatives Industry Opportunities and Challenges Table 31. Bovine Blood Plasma Derivatives Industry Restraints Table 32. Global Bovine Blood Plasma Derivatives Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Bovine Blood Plasma Derivatives Revenue Market Share by Company (2021-2026) Table 34. Global Bovine Blood Plasma Derivatives Sales by Company (2021-2026) & (K Liters) Table 35. Global Bovine Blood Plasma Derivatives Sales Share by Company (2021-2026) Table 36. Global Bovine Blood Plasma Derivatives Market Price by Company (2021-2026) & (USD/L) Table 37. Global Bovine Blood Plasma Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Bovine Blood Plasma Derivatives Major Company Production Sites and Headquarters Table 39. Global Bovine Blood Plasma Derivatives Company, Product Type & Application Table 40. Global Bovine Blood Plasma Derivatives Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Bovine Blood Plasma Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Bovine Blood Plasma Derivatives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Bovine Blood Plasma Derivatives Sales by Region (2021-2026) & (K Liters) Table 45. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Region (2021-2026) Table 46. Global Bovine Blood Plasma Derivatives Sales by Region (2021-2026) & (US$ Million) Table 47. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Region (2021-2026) Table 48. Global Bovine Blood Plasma Derivatives Sales (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 49. Global Bovine Blood Plasma Derivatives Sales by Region (2027-2032) & (K Liters) Table 50. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Region (2027-2032) Table 51. Global Bovine Blood Plasma Derivatives Sales by Region (2027-2032) & (US$ Million) Table 52. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Region (2027-2032) Table 53. Global Bovine Blood Plasma Derivatives Sales (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2027-2032) Table 54. Global Bovine Blood Plasma Derivatives Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (K Liters) Table 56. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application (2021-2026) Table 57. Global Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (US$ Million) Table 58. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Application (2021-2026) Table 59. Global Bovine Blood Plasma Derivatives Price by Application (2021-2026) & (USD/L) Table 60. Global Bovine Blood Plasma Derivatives Sales by Application (2027-2032) & (K Liters) Table 61. Global Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application (2027-2032) Table 62. Global Bovine Blood Plasma Derivatives Sales by Application (2027-2032) & (US$ Million) Table 63. Global Bovine Blood Plasma Derivatives Sales Market Share in Value by Application (2027-2032) Table 64. Global Bovine Blood Plasma Derivatives Price by Application (2027-2032) & (USD/L) Table 65. North America Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (K Liters) Table 66. North America Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (K Liters) Table 68. Europe Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (K Liters) Table 70. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (K Liters) Table 72. Latin America Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (K Liters) Table 74. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Application (2021-2026) & (US$ Million) Table 75. Thermo Fisher Company Information Table 76. Thermo Fisher Business Overview Table 77. Thermo Fisher Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 78. Thermo Fisher Bovine Blood Plasma Derivatives Product Portfolio Table 79. Thermo Fisher Recent Development Table 80. GE Healthcare Company Information Table 81. GE Healthcare Business Overview Table 82. GE Healthcare Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 83. GE Healthcare Bovine Blood Plasma Derivatives Product Portfolio Table 84. GE Healthcare Recent Development Table 85. Merck (Sigma-Aldrich) Company Information Table 86. Merck (Sigma-Aldrich) Business Overview Table 87. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 88. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Portfolio Table 89. Merck (Sigma-Aldrich) Recent Development Table 90. Moregate BioTech Company Information Table 91. Moregate BioTech Business Overview Table 92. Moregate BioTech Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 93. Moregate BioTech Bovine Blood Plasma Derivatives Product Portfolio Table 94. Moregate BioTech Recent Development Table 95. Gemini Company Information Table 96. Gemini Business Overview Table 97. Gemini Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 98. Gemini Bovine Blood Plasma Derivatives Product Portfolio Table 99. Gemini Recent Development Table 100. Atlanta Biologicals Company Information Table 101. Atlanta Biologicals Business Overview Table 102. Atlanta Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 103. Atlanta Biologicals Bovine Blood Plasma Derivatives Product Portfolio Table 104. Atlanta Biologicals Recent Development Table 105. Tissue Culture Biologicals Company Information Table 106. Tissue Culture Biologicals Business Overview Table 107. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 108. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Portfolio Table 109. Tissue Culture Biologicals Recent Development Table 110. Bovogen Company Information Table 111. Bovogen Business Overview Table 112. Bovogen Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 113. Bovogen Bovine Blood Plasma Derivatives Product Portfolio Table 114. Bovogen Recent Development Table 115. Biowest Company Information Table 116. Biowest Business Overview Table 117. Biowest Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 118. Biowest Bovine Blood Plasma Derivatives Product Portfolio Table 119. Biowest Recent Development Table 120. Internegocios Company Information Table 121. Internegocios Business Overview Table 122. Internegocios Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 123. Internegocios Bovine Blood Plasma Derivatives Product Portfolio Table 124. Internegocios Recent Development Table 125. RMBIO Company Information Table 126. RMBIO Business Overview Table 127. RMBIO Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 128. RMBIO Bovine Blood Plasma Derivatives Product Portfolio Table 129. RMBIO Recent Development Table 130. Biological Industries Company Information Table 131. Biological Industries Business Overview Table 132. Biological Industries Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 133. Biological Industries Bovine Blood Plasma Derivatives Product Portfolio Table 134. Biological Industries Recent Development Table 135. VWR Company Information Table 136. VWR Business Overview Table 137. VWR Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 138. VWR Bovine Blood Plasma Derivatives Product Portfolio Table 139. VWR Recent Development Table 140. Corning Company Information Table 141. Corning Business Overview Table 142. Corning Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 143. Corning Bovine Blood Plasma Derivatives Product Portfolio Table 144. Corning Recent Development Table 145. Serana Company Information Table 146. Serana Business Overview Table 147. Serana Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 148. Serana Bovine Blood Plasma Derivatives Product Portfolio Table 149. Serana Recent Development Table 150. Lanzhou Minhai Company Information Table 151. Lanzhou Minhai Business Overview Table 152. Lanzhou Minhai Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 153. Lanzhou Minhai Bovine Blood Plasma Derivatives Product Portfolio Table 154. Lanzhou Minhai Recent Development Table 155. Zhejiang Tianhang Biotechnology Company Information Table 156. Zhejiang Tianhang Biotechnology Business Overview Table 157. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 158. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Portfolio Table 159. Zhejiang Tianhang Biotechnology Recent Development Table 160. ExCell Bio Company Information Table 161. ExCell Bio Business Overview Table 162. ExCell Bio Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 163. ExCell Bio Bovine Blood Plasma Derivatives Product Portfolio Table 164. ExCell Bio Recent Development Table 165. Jin Yuan Kang Company Information Table 166. Jin Yuan Kang Business Overview Table 167. Jin Yuan Kang Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 168. Jin Yuan Kang Bovine Blood Plasma Derivatives Product Portfolio Table 169. Jin Yuan Kang Recent Development Table 170. American Protein Company Company Information Table 171. American Protein Company Business Overview Table 172. American Protein Company Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 173. American Protein Company Bovine Blood Plasma Derivatives Product Portfolio Table 174. American Protein Company Recent Development Table 175. Sonac Company Information Table 176. Sonac Business Overview Table 177. Sonac Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 178. Sonac Bovine Blood Plasma Derivatives Product Portfolio Table 179. Sonac Recent Development Table 180. North America Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (K Liters): 2021 VS 2025 VS 2032 Table 181. North America Bovine Blood Plasma Derivatives Sales by Country (2021-2026) & (K Liters) Table 182. North America Bovine Blood Plasma Derivatives Sales Market Share by Country (2021-2026) Table 183. North America Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032) & (K Liters) Table 184. North America Bovine Blood Plasma Derivatives Sales Market Share Forecast by Country (2027-2032) Table 185. North America Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 186. North America Bovine Blood Plasma Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 187. North America Bovine Blood Plasma Derivatives Market Share by Country (2021-2026) Table 188. North America Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 189. North America Bovine Blood Plasma Derivatives Market Share Forecast by Country (2027-2032) Table 190. Europe Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (K Liters): 2021 VS 2025 VS 2032 Table 191. Europe Bovine Blood Plasma Derivatives Sales by Country (2021-2026) & (K Liters) Table 192. Europe Bovine Blood Plasma Derivatives Sales Market Share by Country (2021-2026) Table 193. Europe Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032) & (K Liters) Table 194. Europe Bovine Blood Plasma Derivatives Sales Market Share Forecast by Country (2027-2032) Table 195. Europe Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 196. Europe Bovine Blood Plasma Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 197. Europe Bovine Blood Plasma Derivatives Market Share by Country (2021-2026) Table 198. Europe Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 199. Europe Bovine Blood Plasma Derivatives Market Share Forecast by Country (2027-2032) Table 200. Asia-Pacific Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (K Liters): 2021 VS 2025 VS 2032 Table 201. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Country (2021-2026) & (K Liters) Table 202. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share by Country (2021-2026) Table 203. Asia-Pacific Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032) & (K Liters) Table 204. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share Forecast by Country (2027-2032) Table 205. Asia-Pacific Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 206. Asia-Pacific Bovine Blood Plasma Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 207. Asia-Pacific Bovine Blood Plasma Derivatives Market Share by Country (2021-2026) Table 208. Asia-Pacific Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 209. Asia-Pacific Bovine Blood Plasma Derivatives Market Share Forecast by Country (2027-2032) Table 210. Latin America Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (K Liters): 2021 VS 2025 VS 2032 Table 211. Latin America Bovine Blood Plasma Derivatives Sales by Country (2021-2026) & (K Liters) Table 212. Latin America Bovine Blood Plasma Derivatives Sales Market Share by Country (2021-2026) Table 213. Latin America Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032) & (K Liters) Table 214. Latin America Bovine Blood Plasma Derivatives Sales Market Share Forecast by Country (2027-2032) Table 215. Latin America Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 216. Latin America Bovine Blood Plasma Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 217. Latin America Bovine Blood Plasma Derivatives Market Share by Country (2021-2026) Table 218. Latin America Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 219. Latin America Bovine Blood Plasma Derivatives Market Share Forecast by Country (2027-2032) Table 220. Middle East and Africa Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (K Liters): 2021 VS 2025 VS 2032 Table 221. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2021-2026) & (K Liters) Table 222. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share by Country (2021-2026) Table 223. Middle East and Africa Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032) & (K Liters) Table 224. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share Forecast by Country (2027-2032) Table 225. Middle East and Africa Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 226. Middle East and Africa Bovine Blood Plasma Derivatives Market Size by Country (2021-2026) & (US$ Million) Table 227. Middle East and Africa Bovine Blood Plasma Derivatives Market Share by Country (2021-2026) Table 228. Middle East and Africa Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 229. Middle East and Africa Bovine Blood Plasma Derivatives Market Share Forecast by Country (2027-2032) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Bovine Blood Plasma Derivatives Distributors List Table 233. Bovine Blood Plasma Derivatives Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Bovine Blood Plasma Derivatives Image Figure 2. Global Bovine Blood Plasma Derivatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 4. Global Bovine Blood Plasma Derivatives Sales (2021-2032) & (K Liters) Figure 5. Bovine Serum Image Figure 6. Global Bovine Serum Sales YoY Growth (2021-2032) & (K Liters) Figure 7. FBS Image Figure 8. Global FBS Sales YoY Growth (2021-2032) & (K Liters) Figure 9. Bovine Serum Albumin Image Figure 10. Global Bovine Serum Albumin Sales YoY Growth (2021-2032) & (K Liters) Figure 11. Fibrinogen Image Figure 12. Global Fibrinogen Sales YoY Growth (2021-2032) & (K Liters) Figure 13. Protein Ingredient Image Figure 14. Global Protein Ingredient Sales YoY Growth (2021-2032) & (K Liters) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (K Liters) Figure 17. Global Bovine Blood Plasma Derivatives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Bovine Blood Plasma Derivatives Market Share by Type 2025 VS 2032 Figure 19. North America Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type in 2025 Figure 20. North America Bovine Blood Plasma Derivatives Sales Market Share in Value by Type in 2025 Figure 21. Europe Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type in 2025 Figure 22. Europe Bovine Blood Plasma Derivatives Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share in Value by Type in 2025 Figure 25. Latin America Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Bovine Blood Plasma Derivatives Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Bovine Blood Plasma Derivatives Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Scientific Research Image Figure 32. Global Scientific Research Sales YoY Growth (2021-2032) & (K Liters) Figure 33. Industrial Production Image Figure 34. Global Industrial Production Sales YoY Growth (2021-2032) & (K Liters) Figure 35. Feed Image Figure 36. Global Feed Sales YoY Growth (2021-2032) & (K Liters) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Liters) Figure 39. Global Bovine Blood Plasma Derivatives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Bovine Blood Plasma Derivatives Market Share by Application 2025 VS 2032 Figure 41. North America Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application in 2025 Figure 42. North America Bovine Blood Plasma Derivatives Sales Market Share in Value by Application in 2025 Figure 43. Europe Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application in 2025 Figure 44. Europe Bovine Blood Plasma Derivatives Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share in Value by Application in 2025 Figure 47. Latin America Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Bovine Blood Plasma Derivatives Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share in Value by Application in 2025 Figure 51. North America Bovine Blood Plasma Derivatives Sales by Country: 2021 VS 2025 VS 2032 (K Liters) Figure 52. North America Bovine Blood Plasma Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Bovine Blood Plasma Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Bovine Blood Plasma Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Bovine Blood Plasma Derivatives Sales by Country: 2021 VS 2025 VS 2032 (K Liters) Figure 56. Europe Bovine Blood Plasma Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Bovine Blood Plasma Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Bovine Blood Plasma Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Country: 2021 VS 2025 VS 2032 (K Liters) Figure 60. Asia-Pacific Bovine Blood Plasma Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bovine Blood Plasma Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Bovine Blood Plasma Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Bovine Blood Plasma Derivatives Sales by Country: 2021 VS 2025 VS 2032 (K Liters) Figure 64. Latin America Bovine Blood Plasma Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Bovine Blood Plasma Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Bovine Blood Plasma Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country: 2021 VS 2025 VS 2032 (K Liters) Figure 68. Middle East and Africa Bovine Blood Plasma Derivatives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Bovine Blood Plasma Derivatives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Bovine Blood Plasma Derivatives Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Bovine Blood Plasma Derivatives Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Bovine Blood Plasma Derivatives Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine Serum
  • FBS
  • Bovine Serum Albumin
  • Fibrinogen
  • Protein Ingredient
  • Other
Applications
  • Scientific Research
  • Industrial Production
  • Feed
  • Others
Companies covered
  • Thermo Fisher
  • GE Healthcare
  • Merck (Sigma-Aldrich)
  • Moregate BioTech
  • Gemini
  • Atlanta Biologicals
  • Tissue Culture Biologicals
  • Bovogen
  • Biowest
  • Internegocios
  • RMBIO
  • Biological Industries
  • VWR
  • Corning
  • Serana
  • Lanzhou Minhai
  • Zhejiang Tianhang Biotechnology
  • ExCell Bio
  • Jin Yuan Kang
  • American Protein Company
  • Sonac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bovine Blood Plasma Derivatives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bovine Blood Plasma Derivatives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bovine Blood Plasma Derivatives Market by Type
  6. 1.3.1 Bovine Serum
  7. 1.3.2 FBS
  8. 1.3.3 Bovine Serum Albumin
  9. 1.3.4 Fibrinogen
  10. 1.3.5 Protein Ingredient
  11. 1.3.6 Other
  12. 1.4 Global Bovine Blood Plasma Derivatives Market Size by Type
  13. 1.4.1 Global Bovine Blood Plasma Derivatives Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Bovine Blood Plasma Derivatives Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Bovine Blood Plasma Derivatives Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Bovine Blood Plasma Derivatives Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Bovine Blood Plasma Derivatives Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Bovine Blood Plasma Derivatives Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Bovine Blood Plasma Derivatives Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Bovine Blood Plasma Derivatives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bovine Blood Plasma Derivatives Industry Trends
  2. 2.2 Bovine Blood Plasma Derivatives Industry Drivers
  3. 2.3 Bovine Blood Plasma Derivatives Industry Opportunities and Challenges
  4. 2.4 Bovine Blood Plasma Derivatives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bovine Blood Plasma Derivatives Revenue (2021-2026)
  2. 3.2 Global Top Players by Bovine Blood Plasma Derivatives Sales (2021-2026)
  3. 3.3 Global Top Players by Bovine Blood Plasma Derivatives Price (2021-2026)
  4. 3.4 Global Bovine Blood Plasma Derivatives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bovine Blood Plasma Derivatives Major Company Production Sites & Headquarters
  6. 3.6 Global Bovine Blood Plasma Derivatives Company, Product Type & Application
  7. 3.7 Global Bovine Blood Plasma Derivatives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bovine Blood Plasma Derivatives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bovine Blood Plasma Derivatives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bovine Blood Plasma Derivatives Tier 1, Tier 2, and Tier 3
4 Bovine Blood Plasma Derivatives Regional Status and Outlook
  1. 4.1 Global Bovine Blood Plasma Derivatives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bovine Blood Plasma Derivatives Historic Market Size by Region
  3. 4.2.1 Global Bovine Blood Plasma Derivatives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bovine Blood Plasma Derivatives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bovine Blood Plasma Derivatives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bovine Blood Plasma Derivatives Forecasted Market Size by Region
  7. 4.3.1 Global Bovine Blood Plasma Derivatives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bovine Blood Plasma Derivatives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bovine Blood Plasma Derivatives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bovine Blood Plasma Derivatives by Application
  1. 5.1 Bovine Blood Plasma Derivatives Market by Application
  2. 5.1.1 Scientific Research
  3. 5.1.2 Industrial Production
  4. 5.1.3 Feed
  5. 5.1.4 Others
  6. 5.2 Global Bovine Blood Plasma Derivatives Market Size by Application
  7. 5.2.1 Global Bovine Blood Plasma Derivatives Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Bovine Blood Plasma Derivatives Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Bovine Blood Plasma Derivatives Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Bovine Blood Plasma Derivatives Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Bovine Blood Plasma Derivatives Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Bovine Blood Plasma Derivatives Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Bovine Blood Plasma Derivatives Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Bovine Blood Plasma Derivatives Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher
  2. 6.1.1 Thermo Fisher Company Information
  3. 6.1.2 Thermo Fisher Business Overview
  4. 6.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Product Portfolio
  6. 6.1.5 Thermo Fisher Recent Developments
  7. 6.2 GE Healthcare
  8. 6.2.1 GE Healthcare Company Information
  9. 6.2.2 GE Healthcare Business Overview
  10. 6.2.3 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GE Healthcare Bovine Blood Plasma Derivatives Product Portfolio
  12. 6.2.5 GE Healthcare Recent Developments
  13. 6.3 Merck (Sigma-Aldrich)
  14. 6.3.1 Merck (Sigma-Aldrich) Company Information
  15. 6.3.2 Merck (Sigma-Aldrich) Business Overview
  16. 6.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Portfolio
  18. 6.3.5 Merck (Sigma-Aldrich) Recent Developments
  19. 6.4 Moregate BioTech
  20. 6.4.1 Moregate BioTech Company Information
  21. 6.4.2 Moregate BioTech Business Overview
  22. 6.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Product Portfolio
  24. 6.4.5 Moregate BioTech Recent Developments
  25. 6.5 Gemini
  26. 6.5.1 Gemini Company Information
  27. 6.5.2 Gemini Business Overview
  28. 6.5.3 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gemini Bovine Blood Plasma Derivatives Product Portfolio
  30. 6.5.5 Gemini Recent Developments
  31. 6.6 Atlanta Biologicals
  32. 6.6.1 Atlanta Biologicals Company Information
  33. 6.6.2 Atlanta Biologicals Business Overview
  34. 6.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Product Portfolio
  36. 6.6.5 Atlanta Biologicals Recent Developments
  37. 6.7 Tissue Culture Biologicals
  38. 6.7.1 Tissue Culture Biologicals Company Information
  39. 6.7.2 Tissue Culture Biologicals Business Overview
  40. 6.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Portfolio
  42. 6.7.5 Tissue Culture Biologicals Recent Developments
  43. 6.8 Bovogen
  44. 6.8.1 Bovogen Company Information
  45. 6.8.2 Bovogen Business Overview
  46. 6.8.3 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bovogen Bovine Blood Plasma Derivatives Product Portfolio
  48. 6.8.5 Bovogen Recent Developments
  49. 6.9 Biowest
  50. 6.9.1 Biowest Company Information
  51. 6.9.2 Biowest Business Overview
  52. 6.9.3 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biowest Bovine Blood Plasma Derivatives Product Portfolio
  54. 6.9.5 Biowest Recent Developments
  55. 6.10 Internegocios
  56. 6.10.1 Internegocios Company Information
  57. 6.10.2 Internegocios Business Overview
  58. 6.10.3 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Internegocios Bovine Blood Plasma Derivatives Product Portfolio
  60. 6.10.5 Internegocios Recent Developments
  61. 6.11 RMBIO
  62. 6.11.1 RMBIO Company Information
  63. 6.11.2 RMBIO Business Overview
  64. 6.11.3 RMBIO Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 RMBIO Bovine Blood Plasma Derivatives Product Portfolio
  66. 6.11.5 RMBIO Recent Developments
  67. 6.12 Biological Industries
  68. 6.12.1 Biological Industries Company Information
  69. 6.12.2 Biological Industries Business Overview
  70. 6.12.3 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Biological Industries Bovine Blood Plasma Derivatives Product Portfolio
  72. 6.12.5 Biological Industries Recent Developments
  73. 6.13 VWR
  74. 6.13.1 VWR Company Information
  75. 6.13.2 VWR Business Overview
  76. 6.13.3 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 VWR Bovine Blood Plasma Derivatives Product Portfolio
  78. 6.13.5 VWR Recent Developments
  79. 6.14 Corning
  80. 6.14.1 Corning Company Information
  81. 6.14.2 Corning Business Overview
  82. 6.14.3 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Corning Bovine Blood Plasma Derivatives Product Portfolio
  84. 6.14.5 Corning Recent Developments
  85. 6.15 Serana
  86. 6.15.1 Serana Company Information
  87. 6.15.2 Serana Business Overview
  88. 6.15.3 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Serana Bovine Blood Plasma Derivatives Product Portfolio
  90. 6.15.5 Serana Recent Developments
  91. 6.16 Lanzhou Minhai
  92. 6.16.1 Lanzhou Minhai Company Information
  93. 6.16.2 Lanzhou Minhai Business Overview
  94. 6.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Product Portfolio
  96. 6.16.5 Lanzhou Minhai Recent Developments
  97. 6.17 Zhejiang Tianhang Biotechnology
  98. 6.17.1 Zhejiang Tianhang Biotechnology Company Information
  99. 6.17.2 Zhejiang Tianhang Biotechnology Business Overview
  100. 6.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Portfolio
  102. 6.17.5 Zhejiang Tianhang Biotechnology Recent Developments
  103. 6.18 ExCell Bio
  104. 6.18.1 ExCell Bio Company Information
  105. 6.18.2 ExCell Bio Business Overview
  106. 6.18.3 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 ExCell Bio Bovine Blood Plasma Derivatives Product Portfolio
  108. 6.18.5 ExCell Bio Recent Developments
  109. 6.19 Jin Yuan Kang
  110. 6.19.1 Jin Yuan Kang Company Information
  111. 6.19.2 Jin Yuan Kang Business Overview
  112. 6.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Product Portfolio
  114. 6.19.5 Jin Yuan Kang Recent Developments
  115. 6.20 American Protein Company
  116. 6.20.1 American Protein Company Company Information
  117. 6.20.2 American Protein Company Business Overview
  118. 6.20.3 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 American Protein Company Bovine Blood Plasma Derivatives Product Portfolio
  120. 6.20.5 American Protein Company Recent Developments
  121. 6.21 Sonac
  122. 6.21.1 Sonac Company Information
  123. 6.21.2 Sonac Business Overview
  124. 6.21.3 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Sonac Bovine Blood Plasma Derivatives Product Portfolio
  126. 6.21.5 Sonac Recent Developments
7 North America by Country
  1. 7.1 North America Bovine Blood Plasma Derivatives Sales by Country
  2. 7.1.1 North America Bovine Blood Plasma Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bovine Blood Plasma Derivatives Sales by Country (2021-2026)
  4. 7.1.3 North America Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bovine Blood Plasma Derivatives Market Size by Country
  6. 7.2.1 North America Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bovine Blood Plasma Derivatives Market Size by Country (2021-2026)
  8. 7.2.3 North America Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bovine Blood Plasma Derivatives Sales by Country
  2. 8.1.1 Europe Bovine Blood Plasma Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bovine Blood Plasma Derivatives Sales by Country (2021-2026)
  4. 8.1.3 Europe Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bovine Blood Plasma Derivatives Market Size by Country
  6. 8.2.1 Europe Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bovine Blood Plasma Derivatives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bovine Blood Plasma Derivatives Sales by Country
  2. 9.1.1 Asia-Pacific Bovine Blood Plasma Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bovine Blood Plasma Derivatives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bovine Blood Plasma Derivatives Market Size by Country
  6. 9.2.1 Asia-Pacific Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bovine Blood Plasma Derivatives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bovine Blood Plasma Derivatives Sales by Country
  2. 10.1.1 South America Bovine Blood Plasma Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bovine Blood Plasma Derivatives Sales by Country (2021-2026)
  4. 10.1.3 South America Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bovine Blood Plasma Derivatives Market Size by Country
  6. 10.2.1 South America Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bovine Blood Plasma Derivatives Market Size by Country (2021-2026)
  8. 10.2.3 South America Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country
  2. 11.1.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bovine Blood Plasma Derivatives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bovine Blood Plasma Derivatives Market Size by Country
  6. 11.2.1 Middle East and Africa Bovine Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bovine Blood Plasma Derivatives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bovine Blood Plasma Derivatives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bovine Blood Plasma Derivatives Value Chain Analysis
  2. 12.1.1 Bovine Blood Plasma Derivatives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bovine Blood Plasma Derivatives Production Mode & Process
  7. 12.2 Bovine Blood Plasma Derivatives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bovine Blood Plasma Derivatives Distributors
  10. 12.2.3 Bovine Blood Plasma Derivatives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst